In the world of nuclear medicine, health care professionals face the challenge of safeguarding themselves and their patients ...

Medical physicists at the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) have worked with the ...

Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic and neurological ...

In the fourth quarter, we expect updated dose escalation data for NBTXR3 in pancreatic cancer ... Fast Track designation for the investigation of NBTXR3 activated by radiation therapy, with or without ...